The specialty chemical stock hit a 52-week high of Rs 2792 on 3rd January 2024. It has risen more than 4% in a week, and over 13% in the last 3 months.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale